dc.contributor.author | Gamble, David T | |
dc.contributor.author | Clark, Allan B. | |
dc.contributor.author | Luben, Robert N. | |
dc.contributor.author | Wareham, Nicholas J. | |
dc.contributor.author | Khaw, Kay-Tee | |
dc.contributor.author | Myint, Phyo K. | |
dc.date.accessioned | 2019-02-14T00:05:35Z | |
dc.date.available | 2019-02-14T00:05:35Z | |
dc.date.issued | 2018-04-01 | |
dc.identifier.citation | Gamble , D T , Clark , A B , Luben , R N , Wareham , N J , Khaw , K-T & Myint , P K 2018 , ' Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population ' , International Journal of Epidemiology , vol. 47 , no. 2 , pp. 625-633 . https://doi.org/10.1093/ije/dyx265 | en |
dc.identifier.issn | 0300-5771 | |
dc.identifier.other | PURE: 112138269 | |
dc.identifier.other | PURE UUID: 3418a81d-c875-492c-98f3-75235c6a25e0 | |
dc.identifier.other | Scopus: 85052504743 | |
dc.identifier.uri | http://hdl.handle.net/2164/11915 | |
dc.description | The EPIC-Norfolk study was supported by grants from the Medical Research Council (G1000143) and Cancer Research UK (14136). Funders and sponsors had no role in design, interpretation or writing of the article. | en |
dc.format.extent | 9 | |
dc.language.iso | eng | |
dc.relation.ispartof | International Journal of Epidemiology | en |
dc.rights | This is a pre-copyedited, author-produced version of an article accepted for publication in International Journal of Epidemiology following peer review. The version of record Gamble, DT, Clark, AB, Luben, RN, Wareham, NJ, Khaw, K-T & Myint, PK 2018, 'Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population' International Journal of Epidemiology, vol 47, no. 2, pp. 625-633. is available online at: https://doi.org/10.1093/ije/dyx265 | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | anticholinergic burden | en |
dc.subject | stroke | en |
dc.subject | mortality | en |
dc.subject | incidence | en |
dc.subject | epidemiology | en |
dc.subject | R Medicine (General) | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | G1000143 | en |
dc.subject | Cancer Research UK | en |
dc.subject | 14136 | en |
dc.subject.lcc | R1 | en |
dc.title | Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Education | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1093/ije/dyx265 | |
dc.date.embargoedUntil | 2019-02-14 | |
dc.identifier.vol | 47 | en |
dc.identifier.iss | 2 | en |